0001104659-20-122542.txt : 20201106 0001104659-20-122542.hdr.sgml : 20201106 20201106163215 ACCESSION NUMBER: 0001104659-20-122542 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200810 FILED AS OF DATE: 20201106 DATE AS OF CHANGE: 20201106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shah Rajeev M. CENTRAL INDEX KEY: 0001619841 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38722 FILM NUMBER: 201294908 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kolchinsky Peter CENTRAL INDEX KEY: 0001384859 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38722 FILM NUMBER: 201294909 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RA Capital Healthcare Fund LP CENTRAL INDEX KEY: 0001315082 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38722 FILM NUMBER: 201294910 BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6177782500 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER NAME: FORMER CONFORMED NAME: RA Capital Biotech Fund LP DATE OF NAME CHANGE: 20050121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RA CAPITAL MANAGEMENT, L.P. CENTRAL INDEX KEY: 0001346824 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38722 FILM NUMBER: 201294911 BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2500 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER NAME: FORMER CONFORMED NAME: RA CAPITAL MANAGEMENT, LLC DATE OF NAME CHANGE: 20051213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Orchard Therapeutics plc CENTRAL INDEX KEY: 0001748907 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 108 CANNON STREET CITY: LONDON STATE: X0 ZIP: EC4N 6EU BUSINESS PHONE: 011-44-0-203-3846700 MAIL ADDRESS: STREET 1: 108 CANNON STREET CITY: LONDON STATE: X0 ZIP: EC4N 6EU FORMER COMPANY: FORMER CONFORMED NAME: Orchard Rx Ltd DATE OF NAME CHANGE: 20180802 4 1 tm2035295-2_4.xml OWNERSHIP DOCUMENT X0306 4 2020-08-10 0 0001748907 Orchard Therapeutics plc ORTX 0001346824 RA CAPITAL MANAGEMENT, L.P. 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 0 0 1 0 0001315082 RA Capital Healthcare Fund LP 200 BERKELEY STREET BOSTON MA 02116 0 0 1 0 0001384859 Kolchinsky Peter C/O RA CAPITAL MANAGEMENT, L.P. 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 0 0 1 0 0001619841 Shah Rajeev M. C/O RA CAPITAL MANAGEMENT, L.P. 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 0 0 1 0 Ordinary shares 2020-08-10 4 P 0 14570 4.75 A 9126418 I See footnote Ordinary shares 2020-08-10 4 P 0 6787 4.71 A 9133205 I See footnote Ordinary shares 2020-08-12 4 P 0 16291 4.74 A 9149496 I See footnote Ordinary shares 2020-08-14 4 P 0 13031 4.74 A 9162527 I See footnote Ordinary shares 2020-08-17 4 P 0 8235 4.74 A 9170762 I See footnote Ordinary shares 2020-08-18 4 P 0 45249 4.72 A 9216011 I See footnote Ordinary shares 2020-08-19 4 P 0 55204 4.69 A 9271215 I See footnote Ordinary shares 2020-08-19 4 P 0 9050 4.65 A 9280265 I See footnote Ordinary shares 2020-08-20 4 P 0 58106 4.61 A 9338371 I See footnote Ordinary shares 2020-08-20 4 P 0 4525 4.61 A 9342896 I See footnote Ordinary shares 2020-08-21 4 P 0 54416 4.64 A 9397312 I See footnote Ordinary shares 2020-08-21 4 P 0 10226 4.51 A 9407538 I See footnote Ordinary shares 2020-09-24 4 P 0 473327 4.61 A 9880865 I See footnote RA Capital Management, L.P. (the "Adviser") is the investment manager for the RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The securities reported on this Form 4 are held directly by the Fund. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of such securities, except to the extent of any pecuniary interest therein. This transaction was executed in multiple trades at prices ranging from $4.72 to $4.71; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer. This transaction was executed in multiple trades at prices ranging from $4.75 to $4.70; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer. This transaction was executed in multiple trades at prices ranging from $4.75 to $4.70; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer. This transaction was executed in multiple trades at prices ranging from $4.70 to $4.65; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer. This transaction was executed in multiple trades at prices ranging from $4.65 to $4.55; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer. This transaction was executed in multiple trades at prices ranging from $4.47 to $4.70; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer. This transaction was executed in multiple trades at prices ranging from $4.50 to $4.52; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer. This transaction was executed in multiple trades at prices ranging from $4.57 to $4.71; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer. /s/ Peter Kolchinsky, Manager of RA Capital Management, L.P. 2020-11-06 /s/ Peter Kolchinsky, Manager of RA Capital Healthcare GP, LLC, the General Partner of RA Capital Healthcare Fund, L.P. 2020-11-06 /s/ Peter Kolchinsky 2020-11-06 /s/ Rajeev Shah 2020-11-06